Godolphin, P. J., Fisher, D. J., Berry, L. R., Derde, L. P. G., Diaz, J. V., Gordon, A. C., . . . Vale, C. L. (2022). Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis. PloS one, 17(7), e0270668. https://doi.org/10.1371/journal.pone.0270668
Citácia podle Chicago (17th ed.)Godolphin, Peter J., et al. "Association Between Tocilizumab, Sarilumab and All-cause Mortality at 28 Days in Hospitalised Patients with COVID-19: A Network Meta-analysis." PloS One 17, no. 7 (2022): e0270668. https://doi.org/10.1371/journal.pone.0270668.
Citácia podľa MLA (8th ed.)Godolphin, Peter J., et al. "Association Between Tocilizumab, Sarilumab and All-cause Mortality at 28 Days in Hospitalised Patients with COVID-19: A Network Meta-analysis." PloS One, vol. 17, no. 7, 2022, p. e0270668, https://doi.org/10.1371/journal.pone.0270668.